01Facts
The Plaintiff, a member of the Danone Group, is the registered proprietor of the trademark ‘PROTINEX’, used in India since 1957 for protein supplements.
¶ 9.1–9.2The Plaintiff alleged that Defendant No. 1 (marketed by) and Defendant No. 4 (manufactured by) were using the mark ‘PROTEX’ (Impugned Mark No. 1), while Defendants 4–6 were using ‘PROTRILEX’ (Impugned Mark No. 2) for identical goods.
¶ 9.7–9.8Notably, Defendants 4–6 had previously settled a similar infringement suit (CS(COMM) 306/2020) regarding the mark ‘PROTILEX’ but continued infringing activities.
¶ 9.9Despite being duly served, Defendants 1, 3, 4, 5, and 6 failed to file written statements within the statutory period, leading the court to close their right to defense and proceed ex-parte.
¶ 5–7The Plaintiff subsequently moved an application for summary judgment under Order XIII-A of the CPC.
¶ 102Issues
i.1. Whether the Plaintiff is entitled to a summary judgment against the Defendants under Order XIII-A of the CPC due to the lack of a real prospect of a successful defense.
¶ 1, 12ii.2. Whether the Impugned Marks ‘PROTEX’ and ‘PROTRILEX’ are deceptively similar to the Plaintiff’s registered mark ‘PROTINEX’, causing a likelihood of confusion.
¶ 14–1503Law Applied
The court applied Order XIII-A of the Code of Civil Procedure (CPC), 1908, which allows for summary judgment in commercial disputes when a party has no real prospect of successfully defending the claim.
¶ 1Regarding trademark infringement, the court relied on Section 29 of the Trade Marks Act, 1999, which defines deceptive similarity.
¶ 13It further invoked the "Initial Interest Confusion Test" as established in Under Armour Inc. v. Anish Agarwal, holding that confusion even at the initial stage is sufficient to attract infringement.
¶ 13Additionally, the court cited Inter Ikea Systems BV v. Imtiaz Ahamed to establish that defendants should not benefit from evading court proceedings.
¶ 11Provisions in the judgment · 1
Trade Marks Act, 1999 Section 29, 135
04Reasoning
The court found that the Plaintiff established a strong case of statutory and common law rights through continuous use since 1957 and extensive registrations.
¶ 9.2, 14Upon comparison, the court noted that ‘PROTEX’ was derived by merely omitting the letters ‘IN’ from ‘PROTINEX’, and ‘PROTRILEX’ was created by substituting ‘N’ with ‘L’ and adding ‘R’. These minor/cosmetic variations were deemed "dishonest adoptions" intended to ride upon the Plaintiff’s goodwill.
¶ 9.11, 14, 16Applying the Initial Interest Confusion Test, the court reasoned that the structural, visual, and phonetic similarities would inevitably lead the public to associate the Defendants’ products with the Plaintiff.
¶ 15Since the Defendants failed to raise any defense or participate in trial, the court concluded there were no "real prospects" for a successful defense, making the matter fit for summary adjudication without a full trial.
¶ 12, 1605Holding
The court answered both issues in the affirmative, allowing the application for summary judgment. It held that the Impugned Marks were deceptively similar to ‘PROTINEX’ and that the Defendants' actions constituted infringement and passing off.
¶ 15–17The suit was decreed in favor of the Plaintiff against Defendant Nos. 1, 3, 4, 5, and 6, granting a permanent injunction and the reliefs prayed for in Paragraph 125(a) to (e) of the Suit. The court ordered the preparation of the decree sheet and disposed of all pending applications.
¶ 18–20Original Court PDF
Danone Asia Pacific Holdings Pte. Ltd.vsM/S Rockwell Pharmaceuticals & Ors.
Click to open original judgment
Original judgment, available to read, download and summarize on LawLens.in
